La cadena de opciones muestra datos clave de las opciones de acciones de Jeffs Brands a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Jeffs Brands..

Jeffs Brands (NASDAQ:JFBR) Bolsa, Cadena de Opciones

Jeffs Brands

Jeffs Brands Ltd is an e-commerce CPG company, operating on Amazon. The company serves as the holding company of other e-commerce companies, Smart Repair Pro, Purex, and Top Rank, that operate online stores for the sale of various consumer products on Amazon online marketplace, utilizing the FBA model. The company has five wholly-owned subsidiaries: Smart Repair Pro, Purex, Top Rank , Fort and Jeffs' Brands Holdings. The company also utilizes internal methodologies to analyze sales data and patterns on Amazon in order to identify existing stores, niches and products that have the potential for development and growth, and for maximizing sales of existing proprietary products.

Jeffs Brands Ltd

Order Follows Successful Trials and is the Hyzon's Second Fuel Cell Refuse Vehicle Order

News

HYZN

Hyzon Secures Order For Hydrogen Fuel Cell Trucks From South San Francisco Scavenger Company After Successful Trials

WIIM

Pfizer shares are trading higher after the company issued its 2025 outlook.

Susquehanna analyst James Friedman initiates coverage on Globant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLOB#NYSE">GLOB</a>) with a Positive rating and announces Price Target of $255.

Price Target

Initiation

Analyst Ratings

GLOB

Susquehanna Initiates Coverage On Globant with Positive Rating, Announces Price Target of $255

JP Morgan analyst Benjamin Rossi assumes Universal Health Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) with a Neutral rating and announces Price Target of $226.

JP Morgan Assumes Universal Health Servs at Neutral, Announces Price Target of $226

On Monday, Lockheed Martin Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) revealed the launch of the seventh Lockheed Martin-designed and built Global Positioning System (GPS) III satellite, <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/n42522602/seventh-lockheed-martin-built-gps-iii-satellite-launches-supporting-next-gen-constellation-moderni" rel="noreferrer noopener">GPS III SV07, at 7:52 p.m. ET</a>.
The GPS III SV07 spacecraft, built at Lockheed Martin&#8217;s Littleton, Colorado, facility, was transported by ground to its Florida launch site after its usual military aircraft was reassigned for hurricane relief efforts.
The satellite was launched into orbit 12,550 miles above Earth from Cape Canaveral Space Force Station in Florida.
Carefully planning the 2,337-mile route and tracking Hurricane Milton, the spacecraft completed a six-day journey, avoiding severe weather and arriving for final launch preparations.
The team has successfully completed signal acquisition of GPS III SV07, and the spacecraft is now under operational control at Lockheed Martin&#8217;s Denver Launch &amp; Checkout Operations Center until it is officially accepted into the current 31-satellite operational GPS constellation.
Launched on an accelerated timeline, GPS III SV07 joins the Space Force&#8217;s efforts to modernize the GPS constellation, following the launch of GPS III SV06 in 2023.
Malik Musawwir, vice president of Navigation Systems at Lockheed Martin said, &#8220;We supported our customer&#8217;s vision for an accelerated launch of this GPS satellite, ultimately helping them achieve quick-turn operational readiness.&#8221;
&#8220;Time is of the essence for national security missions, and we quickly delivered this critical capability for the Space Force to support rapid demand for secure, advanced positioning, navigation, and timing signals.&#8221;
Investors can gain exposure to the stock via iShares U.S. Aerospace &amp; Defense ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ITA#BATS">ITA</a>) and Global X Funds Global X Defense Tech ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHLD#NYSE">SHLD</a>).
Price Action: LMT shares are down 0.38% at $489.79 premarket at the last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/12/42500980/palantir-surges-over-3-in-overnight-trading-after-army-navy-game-spotlight-elon-musk-and-trumps-presence-and-nasdaq-100-inclusion" target="_blank" rel="noreferrer noopener">Palantir Surges Over 3% In Overnight Trading After Army-Navy Game Spotlight, Elon Musk And Trump&#8217;s Presence, And Nasdaq 100 Inclusion</a></li>
</ul>
Photo via Shutterstock.

Equities

Large Cap

SHLD

Mission Accomplished: Lockheed Martin's GPS III SV07 Successfully Deployed

ZVRA

Zevra Therapeutics To Be Included Nasdaq Biotechnology Index, Effective December 23, 2024

RCAT

Red Cat Holdings shares are trading lower after the company reported worse-than-expected Q2 financial results.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>BMO Capital analyst John McNulty upgraded the rating for Ecolab Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ECL#NYSE">ECL</a>) from Market Perform to Outperform and raised the price target from $279 to $290. Ecolab shares closed at $248.40 on Monday. See how other analysts view this stock.</li>
<li>JP Morgan analyst Robbie Marcus upgraded Zimmer Biomet Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZBH#NYSE">ZBH</a>) from Neutral to Overweight and increased the price target from $125 to $128. Zimmer Biomet shares closed at $106.85 on Monday. <a href="https://www.benzinga.com/quote/ZBH/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Stifel analyst Adam Borg upgraded the rating for Cloudflare, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NET#NYSE">NET</a>) from Hold to Buy and raised the price target from $95 to $136. Cloudflare shares closed at $114.65 on Monday. <a href="https://www.benzinga.com/quote/NET/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley analyst Erin Wright upgraded Quest Diagnostics Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DGX#NYSE">DGX</a>) from Equal-Weight to Overweight and raised the price target from $145 to $172. Quest Diagnostics shares closed at $152.65 on Monday. See how other analysts view this stock.</li>
<li>Mizuho analyst Vijay Rakesh upgraded the rating for Tesla, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) from Neutral to Outperform and boosted the price target from $230 to $515. Tesla shares closed at $463.02 on Monday. <a href="https://www.benzinga.com/quote/TSLA/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying TSLA stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="1012" height="485" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/17074009/image-145.png" alt="" class="wp-image-695651" style="width:591px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/17074009/image-145.png 1012w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/17074009/image-145-300x144.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/17074009/image-145-768x368.png 768w" sizes="(max-width: 1012px) 100vw, 1012px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/12/42507875/how-to-earn-500-a-month-from-worthington-enterprises-stock-ahead-of-q2-earnings">How To Earn $500 A Month From Worthington Enterprises Stock Ahead Of Q2 Earnings</a></li>
</ul>

Upgrades

Pre-Market Outlook

Markets

Trading Ideas

TSLA

This Tesla Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

JP Morgan analyst Benjamin Rossi assumes HCA Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) with a Neutral rating and announces Price Target of $380.

JP Morgan Assumes HCA Healthcare at Neutral, Announces Price Target of $380

PDD Holdings&#8216; (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>) Temu app has once again secured the top position as the most downloaded free app on Apple&#8217;s U.S. iOS store, marking its second consecutive year at the summit. 
What Happened: This achievement comes amid increasing scrutiny of Chinese companies by U.S. authorities, CNBC <a href="https://www.cnbc.com/2024/12/17/temu-tops-us-ios-downloads-for-2nd-year-amid-greater-scrutiny-of-china-firms.html">reported</a> on Tuesday.
The Biden administration is proposing measures to address the &#8220;overuse and abuse&#8221; of the de minimis provision, which allows duty-free imports for shipments under $800. This could affect Temu and other companies like Shein by potentially raising costs and reducing their competitive edge.
Additionally, President-elect Donald Trump has suggested tariffs of 60% to 100% on Chinese imports, though it&#8217;s uncertain if these will be enacted. This aligns with his campaign&#8217;s focus on limiting Chinese imports. Meanwhile, countries like Vietnam and Indonesia have already taken action against Chinese imports, with Vietnam banning Temu shortly after its launch there. A report from Nomura indicates that changes to the de minimis rule could significantly impact China&#8217;s export growth to the U.S. in 2025.
See Also: <a href="https://www.benzinga.com/24/12/42495579/lawmakers-demand-apple-and-google-remove-tiktok-by-jan-19-what-you-need-to-know?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Apple, Google Directed To Remove TikTok From Respective App Stores By Jan 19: Here&#8217;s What You Need To Know</a>
Why It Matters: The proposed changes to the de minimis exemption are part of a broader effort by the Biden administration to curb the influx of low-value goods from Chinese e-commerce platforms like PDD Holdings and Shein. The <a href="https://www.benzinga.com/government/24/09/40853105/team-biden-targets-shein-and-temu-with-new-rules-to-curb-abuse-of-us-trade-loophole-by-chinese-e-com">Biden-Harris Administration</a> has expressed concerns over the increased abuse of this loophole, which has seen shipments claiming this exemption surge from about 140 million to over a billion annually.
The potential tariffs proposed by President-elect Trump could further complicate the landscape for Chinese imports. As noted by JPMorgan analyst Christopher Horvers, these <a href="https://www.benzinga.com/government/regulations/24/11/42213610/hasbro-best-buy-brace-as-trumps-tariffs-loom-could-retail-margins-hit-rock-bottom">tariffs could be more challenging</a> to absorb now than during the previous trade tensions in 2019, given the current economic conditions.
Moreover, PDD Holdings recently reported a fiscal <a href="https://www.benzinga.com/24/11/42111158/pdd-holdings-3-earnings-misses-expectations-reports-strong-transaction-growth-but-faces-challenges-in-competitive-market-shares-plunge">third-quarter revenue growth</a> of 44% year-on-year, but missed analyst expectations, highlighting the intensified competition and external challenges faced by the company.
Price Action: PDD closed 2.60% lower at $99.61 on Monday while it was up by 0.58% and trading at $100.17 at 7:28 am ET, as per <a href="https://pro.benzinga.com">Benzinga Pro</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/tech/24/12/42383967/how-to-use-apple-watch-as-a-digital-key-for-your-tesla-car?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">How To Use Apple Watch As A Digital Key For Your Tesla Car</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo: Mehaniq/Shutterstock.com

Tech

General

Citigourp Global Markets 2% Protected Notes Linked To The Djia

PDD's Temu Tops iOS Downloads In US While Trump Wants To Impose 100% Tariffs On Chinese Imports

American Shared Hospital Services Secures Certificate Of Need For Proton Therapy Facility In Rhode Island

ZENA

ZenaTech shares are trading higher after the company signed a letter of intent to acquire a land survey engineering company and announced plans to add quantum computing to its AI drone capabilities to accommodate large-size datasets.

Sanofi shares are trading higher after the company and Teva announced that primary endpoints were met in the Phase 2b trial of Duvakitug for ulcerative colitis and Crohn's disease.

TEVA

Teva shares are trading higher after the company and Sanofi announced that primary endpoints were met in the Phase 2b trial of Duvakitug for ulcerative colitis and Crohn's disease.

Biotech

PSTV

Plus Therapeutics Highlights Presentation, Says 'Nine of 20 patients with LM primary breast cancer were treated and evaluable through five dose escalation cohorts, with the maximum tolerated dose yet to be reached'

Susquehanna analyst Christopher Rolland initiates coverage on Credo Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRDO#NASDAQ">CRDO</a>) with a Neutral rating and announces Price Target of $80.

CRDO

Susquehanna Initiates Coverage On Credo Technology Group with Neutral Rating, Announces Price Target of $80

"Our team is exploring an initial sales pipeline organically, without expending the operating costs associated with engaging a direct sales force or third-party medical device commercial partners." said BioCardia CEO, Peter Altman, PhD. "We look forward to demonstrating the value of the Morph DNA product family to physicians for procedures throughout the vascular system."

BCDA

BioCardia Launches Commercial Availability Of Morph DNA Steerable Introducer, Expanding Vascular Procedure Tools

JP Morgan analyst Benjamin Rossi assumes Ardent Health Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARDT#NYSE">ARDT</a>) with a Neutral rating and announces Price Target of $20.

ARDT

JP Morgan Assumes Ardent Health Partners at Neutral, Announces Price Target of $20

Key Highlights from the Presentation:
<ul>
<li>Nine of 20 patients with LM primary breast cancer were treated and evaluable through five dose escalation cohorts, with the maximum tolerated dose yet to be reached</li>
<li>Primary breast cancer biomarker status across the 9 patients were:
<ul>
<li>ER positive/HER2 negative: n=3</li>
<li>HER2 positive: n=2</li>
<li>Triple negative: n=4</li>
</ul>
</li>
<li>Patients received a single intrathecal dose of Rhenium (186Re) Obisbemeda, ranging from 6.6 to 66.14 mCi of radiation</li>
<li>Only one dose-limiting toxicity (thrombocytopenia) was reported (Cohort 5)</li>
<li>A linear increase in absorbed dose was observed from Cohorts 1 through 5, with an average absorbed dose of 253 Gy to the cranial subarachnoid space in Cohort 5</li>
<li>Circulating tumor cell (CTC) and radiographic (MRI) response data were available for 8 of the 9 breast cancer patients with LM, and clinical response data were available for 7 of the 9 patients
<ul>
<li>Best response rates (response only) were:
<ul>
<li>CTC: 88% (7/8)</li>
<li>MRI imaging: 25% (2/8)</li>
<li>Clinical: 29% (2/7)</li>
</ul>
</li>
<li>Clinical benefit rates (response and stable disease) were:
<ul>
<li>CTC: 100% (8/8)</li>
<li>MRI imaging: 75% (6/8)</li>
<li>Clinical: 71 % (5/7)</li>
</ul>
</li>
</ul>
</li>
<li>Median overall survival for 9 breast cancer patients was 9 months, with 2 patients surviving beyond 600 days post-treatment</li>
</ul>

Plus Therapeutics Recaps Presentation Of ReSPECT-LM Phase 1 Interim Data At 2024 San Antonio Breast Cancer Symposium

NRDY

Clover School District Teams With Varsity Tutors For Schools To Provide Comprehensive Online Tutoring Resources

Jeffs' Brands (JFBR) has entered into a binding Letter of Intent with Deliverz.AI. The LOI, entered into on November 27, 2024, outlines a plan to e...

Jeffs' Brands, Deliverz.AI sign binding LOI for U.S. joint venture

Jeffs' Brands Ltd. (JFBR) has released an update. Jeffs' Brands Ltd. has reported an impressive 83% increase in sales during November 2024, reachin...

Jeffs' Brands Celebrates Record-Breaking Amazon Sales

Jeffs' Brands (JFBR) entered into an agreement granting it the exclusive worldwide right to distribute certain advanced drone safety systems develo...

Jeffs' Brands secures distribution rights to sell drone safety systems

Jeffs' Brands Ltd. (JFBR) has released an update. Jeffs' Brands Ltd has secured exclusive worldwide rights to distribute advanced drone safety syst...

Jeffs' Brands Gains Exclusive Drone System Distribution Rights

Jeffs' Brands regains compliance with Nasdaq minimum bid price rule

Jeffs' Brands (JFBR) announced that it has received a written notice from Nasdaq, indicating that the company has regained compliance with the mini...

Jeffs' Brands regains compliance with Nasdaq

Jeffs' Brands Ltd. (JFBR) has released an update. Jeffs' Brands Ltd. has successfully regained compliance with Nasdaq's minimum bid price rule as i...

Jeffs' Brands Secures Nasdaq Compliance, Boosts Investor Confidence

Jeffs' Brands (JFBR), a data-driven e-commerce company operating on the Amazon (AMZN) Marketplace, announced that it has entered into an agreement ...

Jeffs' Brands wins global exclusive for drone system distribution on Amazon

Jeffs' Brands files to sell 2.34M ordinary shares for holders

17:20 EST Jeffs' Brands (JFBR) files to sell 2.34M ordinary shares for holders Published first on TheFly – the ultimate source for real-time, marke...

AMZN

JFBR

Press Releases

Jeffs' Brands: Fort (100%) Seeks to Revolutionizes E-Commerce with AI-Based Pest Control App and Bitcoin Payment Integration

Jeffs' Brands and Deliverz.AI Sign a Binding Letter of Intent for a U.S. Joint Venture Involving AI-Powered Fully Autonomous Robots

Jeffs' Brands Announces Trademark Registration Approval for Wellution®, a Wellness and Personal Care Brand (49%) from the USPTO

Jeffs' Brands: Fort Achieves Record-Breaking Sales of $1.2 Million from its Amazon Platform During Black Friday and the November 2024 Shopping Season

Global Medical Service Robotics Market Project to Exceed $20 Billion in 2024 with Additional Growth Expected

Jeffs' Brands Secures Exclusive Worldwide Distribution Rights to Sell Drone Safety Systems on Amazon

Jeffs' Brands Regains Compliance with Nasdaq Minimum Bid Price Rule

"Cardiol Therapeutics (NASDAQ: CRDL) Heart Health Innovation – AVCO, GXAI, UPC, and More Stocks Driving Groundbreaking Advances"

Jeffs' Brands Wins Global Exclusive for Drone System Distribution on Amazon

AVCO

CRDL

GILD

GXAI

JFBRW

MBOT

SERV

ZBAO

Baozun

1stdibs.com

Groupon

Hour Loop

Jumia Technologies AG American Depositary Shares, each representing two Ordinary Shares

Jumia Technologies

Linkage Global Inc - Class A Ordinary Shares

Linkage Global

LightInTheBox Holding Co., Ltd. American Depositary Shares, each representing twelve ordinary shares

LightInTheBox Holding

ContextLogic

MOGU Inc. American Depositary Shares (each representing 25 Class A Ordinary Shares)

Comments

Jeffs Brands

Jeffs Brands (JFBR) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL